The Handmaid Tale is nearing its end, with the final season 6 dropping on the streaming platforms in April. The season will focus on June and her Army for the red revolution.

Arcus Biosciences, Inc. , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today announced that ...

California Democratic Rep. Jared Huffman protested the National Prayer Breakfast Thursday, claiming it violates the ...

TD Cowen raised the firm’s price target on Gilead (GILD) to $100 from $95 and keeps a Buy rating on the shares. The firm said they posted a ...

Wells Fargo analyst Mohit Bansal raised the firm’s price target on Gilead (GILD) to $120 from $105 and keeps an Overweight rating on the ...

Operator Good afternoon, everyone, and welcome to Gilead's fourth quarter and full year 2024 earnings conference call. My ...

Hulu has set the premiere date for The Handmaid’s Tale ‘s sixth and final season for April 8 with a three-episode drop. New episodes will follow weekly on Tuesdays until the May 27 finale.

This was the stock's second consecutive day of losses.

Today's Research Daily features new research reports on 16 major stocks, including Uber Technologies, Inc. (UBER), Comcast Corp. (CMCSA) and Gilead Sciences, Inc. (GILD), as well as a micro-cap ...

Gilead Sciences has shored up its antibody-drug conjugate pipeline by licensing a candidate from German biotech Tubulis in a deal worth up to $415 million. The agreement includes an upfront ...

After years of demands from shareholders for another major deal, Gilead has made a spectacular move, sealing a deal to acquire cell therapy leader Kite for just under $12 billion. Gilead had been ...

The head of the U.N. AIDS agency says the number of new HIV infections could jump more than six times by 2029 if American support of the biggest AIDS program is dropped.